Interestingly, compared with parental cells, ovarian cancer cells resistant to flavopiridol and cisplatin showed the increased expressions of CDK1, cyclin D3 and Rb, decreased expressions of cyclin B, and equal expressions of cyclin A, cyclin E, CDK2, CDK4 [44]. This evidence concerns the gene CCNA2 and ovarian carcinoma.